–
Palvella Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.8
FY22:
−43.5
FY23:
−29.8
FY24:
−14.1
FY25:
−38.6
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−10.5
FY25:
−35.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.7
FY22:
−33.3
FY23:
−24.5
FY24:
−17.4
FY25:
−41.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.7
FY22:
−33.3
FY23:
−24.5
FY24:
−17.4
FY25:
−41.7
All amounts in millions USD